In regards to tax loss selling; it starts in October (not December ...related to the Biotech industry). In regards to MANF; did you ever do any research on "Orphan Drug" strategy?
You can start by looking up more about Amgen (and its history overall). Orphan strategy - will accelerate the timelines...and open up the possibility of getting potential Pharma. drug partnering as well.